IL-17A promotes the migration and invasiveness of cervical cancer cells by coordinately activating MMPs expression via the p38/NF-κB Signal Pathway

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Feng, Minjuan ^a   Wang, Yidong ^a   Chen, Kunlun ^a   Bian, Zhuoqiong ^b   Wu, Jinfang ^a   Gao, Qing ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b The Fifth Hospital of Xi'an City   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; COLLAGENASE 3; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; INTERSTITIAL COLLAGENASE; PROTEIN P50; PYRROLIDINE DITHIOCARBAMATE; STROMELYSIN; STROMELYSIN 2; SYNAPTOPHYSIN; SYNAPTOTAGMIN I; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSCRIPTION FACTOR RELA; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE P38;

ADULT; ARTICLE; CANCER CELL; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CERVICAL CANCER CELL LINE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; DRUG POTENCY; ENZYME ACTIVITY; ENZYME RELEASE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; UTERINE CERVIX CANCER; WESTERN BLOTTING; ENZYMOLOGY; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; TUMOR INVASION; UTERINE CERVIX TUMOR;

ADULT; CELL LINE, TUMOR; FEMALE; HUMANS; INTERLEUKIN-17; MATRIX METALLOPROTEINASES; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; UTERINE CERVICAL NEOPLASMS;

EID: 84907576793     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0108502     Document Type: Article

References (41)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Straussman R, Morikawa T, Shee K, Barzily-Rokni M, Qian ZR, et al. (2012) Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. Nature 487: 500-504.
3. Li M, Li Y, Wen PP (2012) Simulation study of pO(2) distribution in induced tumour masses and normal tissues within a microcirculation environment. Comput Methods Biomech Biomed Engin.
4. Chase HB (1958) Aspects of radiation damage likely to be involved in tumour regression. II. Radiation damage to cells dependent on their tissue environment. Br J Radiol 31: 65-69.
5. Waugh TR (1935) The Environment of Cells as a Factor in Tumour Growth. Can Med Assoc J 33: 542-546.
6. Palomer A, Pascual J, Cabre M, Borras L, Gonzalez G, et al. (2002) Structurebased design of cyclooxygenase-2 selectivity into ketoprofen. Bioorg Med Chem Lett 12: 533-537.
7. Palomer A, Cabre F, Pascual J, Campos J, Trujillo MA, et al. (2002) Identification of novel cyclooxygenase-2 selective inhibitors using pharmacophore models. J Med Chem 45: 1402-1411.
8. Zhu X, Mulcahy LA, Mohammed RA, Lee AH, Franks HA, et al. (2008) IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines. Breast Cancer Res 10: R95.
9. Kataoka H, Tanaka M, Kanamori M, Yoshii S, Ihara M, et al. (2002) Expression profile of EFNB1, EFNB2, two ligands of EPHB2 in human gastric cancer. J Cancer Res Clin Oncol 128: 343-348.
10. Li J, Lau GK, Chen L, Dong SS, Lan HY, et al. (2011) Interleukin 17A promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expression. PLoS One 6: e21816.
11. Gough MJ, Killeen N, Weinberg AD (2012) Targeting macrophages in the tumour environment to enhance the efficacy of alphaOX40 therapy. Immunology 136: 437-447.
12. Chen K, Zhang S, Ji Y, Li J, An P, et al. (2013) Baicalein Inhibits the Invasion and Metastatic Capabilities of Hepatocellular Carcinoma Cells via Down-Regulation of the ERK Pathway. PLoS One 8: e72927.
13. Santiago A, Eicheler W, Bussink J, Rijken P, Yaromina A, et al. (2010) Effect of cetuximab and fractionated irradiation on tumour micro-environment. Radiother Oncol 97: 322-329.
14. Coltrini D, Ronca R, Belleri M, Zardi L, Indraccolo S, et al. (2009) Impact of VEGF-dependent tumour micro-environment on EDB fibronectin expression by subcutaneous human tumour xenografts in nude mice. J Pathol 219: 455-462.
15. Morgan J, Spendlove I, Durrant LG (2002) The role of CD55 in protecting the tumour environment from complement attack. Tissue Antigens 60: 213-223.
16. Pina TC, Zapata IT, Hernandez FC, Lopez JB, Paricio PP, et al. (2001) Tumour markers in serum, bronchoalveolar lavage and biopsy cytosol in lung carcinoma: what environment lends the optimum diagnostic yield? Clin Chim Acta 305: 27-34.
17. Neuhaus SJ, Ellis TS, Barrett MW, Rofe AM, Jamieson GG, et al. (1999) In vitro inhibition of tumour growth in a helium-rich environment: implications for laparoscopic surgery. Aust N Z J Surg 69: 52-55.
18. Kammerer R, von Kleist S (1995) The influence of the local environment on tissue architecture of colorectal carcinoma (CRC) cell aggregates and its consequence for tumour attack by lymphocytes in vitro and in vivo. Eur -J Cancer 31A: 2324-2329.
19. Adams RH, Wilkinson GA, Weiss C, Diella F, Gale NW, et al. (1999) Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev 13: 295-306.
20. Reissenweber B, Mosch B, Pietzsch J (2013) Experimental hypoxia does not influence gene expression and protein synthesis of Eph receptors and ephrin ligands in human melanoma cells in vitro. Melanoma Res 23: 85-95.
21. Doleman JF, Eady JJ, Elliott RM, Foxall RJ, Seers J, et al. (2010) Identification of the Eph receptor pathway as a novel target for eicosapentaenoic acid (EPA) modification of gene expression in human colon adenocarcinoma cells (HT-29). Nutr Metab (Lond) 7: 56.
22. Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161-174.
23. Reunanen N, Li SP, Ahonen M, Foschi M, Han J, et al. (2002) Activation of p38 alpha MAPK enhances collagenase-1 (matrix metalloproteinase (MMP)-1) and stromelysin-1 (MMP-3) expression by mRNA stabilization. J Biol Chem 277: 32360-32368.
24. Zou W (2005) Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer 5: 263-274.
25. Yang XH, Yamagiwa S, Ichida T, Matsuda Y, Sugahara S, et al. (2006) Increase of CD4+ CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma. J Hepatol 45: 254-262.
26. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, et al. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19.
27. Helmerhorst TJ, Meijer CJ (2002) Cervical cancer should be considered as a rare complication of oncogenic HPV infection rather than a STD. Int J Gynecol Cancer 12: 235-236.
28. Fujino S, Andoh A, Bamba S, Ogawa A, Hata K, et al. (2003) Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52: 65-70.
29. Li Q, Chen J, Liu Y, Zhao X, Tan B, et al. (2013) Prevalence of Th17 and Treg cells in gastric cancer patients and its correlation with clinical parameters. Oncol Rep.
30. Souza JM, Matias BF, Rodrigues CM, Murta EF, Michelin MA (2013) IL-17 and IL-22 serum cytokine levels in patients with squamous intraepithelial lesion and invasive cervical carcinoma. Eur J Gynaecol Oncol 34: 466-468.
31. Wang ZD, Huang C, Li ZF, Yang J, Li BH, et al. (2010) Chrysanthemum indicum ethanolic extract inhibits invasion of hepatocellular carcinoma via regulation of MMP/TIMP balance as therapeutic target. Oncol Rep 23: 413-421.
32. Littlepage LE, Sternlicht MD, Rougier N, Phillips J, Gallo E, et al. (2010) Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression. Cancer Res 70: 2224-2234.
33. Okada A (1999) [Roles of matrix metalloproteinases and tissue inhibitor of metalloproteinase (TIMP) in cancer invasion and metastasis]. Gan To Kagaku Ryoho 26: 2247-2252.
34. Murphy G (2011) Tissue inhibitors of metalloproteinases. Genome Biol 12: 233.
35. Zhang Y, Liu J, Kou J, Yu J, Yu B (2012) DT-13 suppresses MDA-MB-435 cell adhesion and invasion by inhibiting MMP-2/9 via the p38 MAPK pathway. Mol Med Rep 6: 1121-1125.
36. Kim ES, Kim MS, Moon A (2004) TGF-beta-induced upregulation of MMP-2 and MMP-9 depends on p38 MAPK, but not ERK signaling in MCF10A human breast epithelial cells. Int J Oncol 25: 1375-1382.
37. Chen Y, Kijlstra A, Yang P (2011) IL-17A stimulates the production of inflammatory mediators via Erk1/2, p38 MAPK, PI3K/Akt, and NF-kappaB pathways in ARPE-19 cells. Mol Vis 17: 3072-3077.
38. Roussel L, Houle F, Chan C, Yao Y, Berube J, et al. (2010) IL-17 promotes p38 MAPK-dependent endothelial activation enhancing neutrophil recruitment to sites of inflammation. J Immunol 184: 4531-4537.
39. Bond M, Fabunmi RP, Baker AH, Newby AC (1998) Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B. FEBS Lett 435: 29-34.
40. Doreau A, Belot A, Bastid J, Riche B, Trescol-Biemont MC, et al. (2009) Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat Immunol 10: 778-785.
41. Shalom-Barak T, Quach J, Lotz M (1998) Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogenactivated protein kinases and NF-kappaB. J Biol Chem 273: 27467-27473.